| Application no. and date | 16200557.3 (espacenet) (Federated) (European Patent Register), 20111206 | | Patent/reg. no. and date | DK/EP 3156420, 20190220 | | Publication date | 20170419 | | Priority no. and date | US 420291 P, 20101206, US 201161446990 P, 20110225 | | EP pub. no. and date |
EP 3156420 20170419 | | Effective date | | | Applicant/owner | SEAGEN INC., 21823 30th Drive, S.E.
Bothell, WA 98021, US | | Applicant ref. no. | T5785_DK | | Inventor | SMITH, Maria Leia, 21823 30th Drive, S.E.
Bothell, WA Washington 98021, US,
SUSSMAN, Django, 21823 30th Drive, S.E.
Bothell, WA Washington 98021, US,
ARTHUR, William, 21823 30th Drive, S.E.
Bothell, WA Washington 98021, US,
NESTEROVA, Albina, 21823 30th Drive, S.E.
Bothell, WA Washington 98021, US | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 35/00 (2006.01) , A61K 39/395 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C12P 21/08 (2006.01) | | Title | HUMANISEREDE ANTISTOFFER TIL LIV-1 OG ANVENDELSE HERAF TIL BEHANDLING AF CANCER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
